Dr. Erlinda Gordon, MD

I appreciate the opportunity to express my deepest gratitude to Dr. Erlinda Gordon for her development of Rexin G targeted gene therapy. In 2006, I was diagnosed with Stage 4 pancreatic cancer and underwent surgery, followed by 18 months of chemotherapy and radiation. In 2008, my pancreatic cancer recurred. This is when I was faced with continuing more chemotherapy, the standard treatment of care. I was left with considering a clinical trial or living the remainder of my life without treatment, which was estimated to be between 6-8 months. After several weeks of research, I discovered and enrolled in a clinical trial for Rexin G by Dr. Erlinda Gordon in Santa Monica, CA. This treatment saved my life, has given me an exceptional quality of life for 16 years. My deepest appreciation to Dr. Gordon for the opportunity she gave me and to so many others.

Dr Gordon fights for her patients and offers them compassion and hope.

I was disheartened to read the negative review about Dr. Erlinda Gordon who ran the clinical trial Rexin-G (Delta Rex-G today) that my Mom successfully received in 2008 and is still with us today. Mom was diagnosed with pancreatic cancer in 2006 and had the Whipple procedure at Duke Univ Cancer Center followed by rounds of chemo and radiation. When in 2008, it appeared her cancer had returned, her oncologist could only offer her more chemo. This was when we found the clinical Trial for Rexin-G and enrolled Mom. Anyone can learn about Dr. Gordon’s background on her Linkedin profile and the Aveni Foundation. Losing a loved one is always hard but the negative portrayal of Dr. Gordon whom we have known for 14 years, is not the professional that we know. Anyone who makes a decision to specialize in pediatric hematology and y and oncology and then further their career into research/drug development to provide cancer patients an alternative is truly a person whose heart and head aligned.